Results 111 to 120 of about 1,508,790 (312)
Molecular Oncology, EarlyView.Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Air pollutant production by algal cell cultures [PDF]
The production of phytotoxic air pollutants by cultures of Chlorella vulgaris and Euglena gracilis is considered. Algal and plant culture systems, a fumigation system, and ethylene, ethane, cyanide, and nitrogen oxides assays are discussed. Bean, tobacco,
Fong, F., Funkhouser, E. A.
core +1 more source
Selection and propagation of superior teak for quality improvement in plantations : case study of the ICSB/Cirad-Forêt joint project [PDF]
, 2005 Innoprise Corporation Sdn Bhd (ICSB), an investment subsidiary of the Sabah Foundation has embarked on an extensive Research and Development program for teak (Tectona grandis), a highly prized timber species. Through ICSB's joint collaboration with CIRAD-
Alloysius, David +5 more
core
LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro
Molecular Oncology, EarlyView.Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix +13 more
wiley +1 more source
Increasing of N-uptake by Inoculation of Diazotroph Endophytic Bacteria in Vermiculite Media [PDF]
, 2007 Intensive selection of selected 15 isolates on N2-fixing activities and auxin production to diazotroph endophytic bacteria showed that five isolates were superior, that is KACP12 (0.2569 μmol hour-1 culture-1), KACP13 (0.3026 μmol hour-1 culture-1 ...
HASTUTI, R. D. (R) +3 more
core
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Pertumbuhan Dan Perkembangan Tunas Puar Tenangau (Elettariopsis SP.) Akibat Perbedaan Periode Sub Kultur [PDF]
, 2014 Puar tenangau is a herbal plant of Zingeberaceae that from Thailand. The Plant has a big potential aspharmacy and traditional medicines, but the spread of this plant was unknown well in Indonesia even soneeded a conservation for this plant.
Ilyas, S. (Syafruddin) +2 more
core
Molecular Oncology, EarlyView.We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology, EarlyView.Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Molecular Oncology, EarlyView.Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source